LU86172A1 - Composition aqueuse de cromoglycate de sodium - Google Patents

Composition aqueuse de cromoglycate de sodium Download PDF

Info

Publication number
LU86172A1
LU86172A1 LU86172A LU86172A LU86172A1 LU 86172 A1 LU86172 A1 LU 86172A1 LU 86172 A LU86172 A LU 86172A LU 86172 A LU86172 A LU 86172A LU 86172 A1 LU86172 A1 LU 86172A1
Authority
LU
Luxembourg
Prior art keywords
composition according
mpa
viscosity
solution
sodium cromoglycate
Prior art date
Application number
LU86172A
Other languages
English (en)
French (fr)
Inventor
Emmett Clemente
Henry Pfeifer
Vincent Hon-Kin Lee
Joseph Robinson
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24706028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU86172(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of LU86172A1 publication Critical patent/LU86172A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
LU86172A 1984-11-23 1985-11-20 Composition aqueuse de cromoglycate de sodium LU86172A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67428284A 1984-11-23 1984-11-23
US67428284 1984-11-23

Publications (1)

Publication Number Publication Date
LU86172A1 true LU86172A1 (fr) 1986-03-24

Family

ID=24706028

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86172A LU86172A1 (fr) 1984-11-23 1985-11-20 Composition aqueuse de cromoglycate de sodium

Country Status (18)

Country Link
EP (1) EP0183457B1 (de)
JP (1) JPH0639379B2 (de)
AT (1) ATE71524T1 (de)
AU (2) AU4999785A (de)
BE (1) BE903701A (de)
CA (1) CA1267848A (de)
CH (1) CH666816A5 (de)
DE (1) DE3585211D1 (de)
DK (1) DK541285A (de)
FR (1) FR2573652B1 (de)
GB (1) GB2167300B (de)
GR (1) GR852791B (de)
IE (1) IE59195B1 (de)
IL (1) IL77086A0 (de)
LU (1) LU86172A1 (de)
NZ (1) NZ214295A (de)
PT (1) PT81538A (de)
ZA (1) ZA858914B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770383A1 (de) 1995-10-24 1997-05-02 Dr. GERHARD MANN chem.-pharm. Fabrik GmbH Ophthalmische Cromolyn-Gelzubereitung

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
EP0444778A1 (de) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Verwendung von Alkylsacchariden zur Förderung der Penetration von Arzneistoffen
DE20022450U1 (de) * 1999-01-19 2002-01-17 Mann Gerhard Chem Pharm Fab Künstliche Tränenflüssigkeit in Gelform
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
WO2005003111A1 (ja) * 2003-07-04 2005-01-13 Astellas Pharma Inc. ウィルス性結膜炎の予防または治療剤
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
EP2248517B1 (de) * 2009-05-08 2014-03-26 PARI Pharma GmbH Konzentrierte mastzellenstabilisierende pharmazeutische Formulierungen
JP2013231185A (ja) * 2013-06-12 2013-11-14 Pfizer Products Inc ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
SI3104853T1 (sl) 2014-02-10 2020-03-31 Respivant Sciences Gmbh Zdravljenje s stabilizatorji mastocitov za sistemske motnje
EP3725311A1 (de) 2014-02-10 2020-10-21 Respivant Sciences GmbH Verfahren zur behandlung von lungenerkrankungen mit mastzellstabilisatoren
WO2017027402A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
CN110139646A (zh) 2016-08-31 2019-08-16 瑞思皮万特科学有限责任公司 用于治疗由特发性肺纤维化引起的慢性咳嗽的色甘酸组合物
AU2017339366A1 (en) 2016-10-07 2019-04-11 Respivant Sciences Gmbh Cromolyn compositions for treatment of pulmonary fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
IL48360A (en) * 1974-11-09 1978-12-17 Fisons Ltd Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
US4268519A (en) * 1979-06-05 1981-05-19 Fisons Limited Method of treating otitis media
JPS5756448A (en) * 1980-09-22 1982-04-05 Mitsui Toatsu Chem Inc Preparation of aromatic isocyanate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770383A1 (de) 1995-10-24 1997-05-02 Dr. GERHARD MANN chem.-pharm. Fabrik GmbH Ophthalmische Cromolyn-Gelzubereitung

Also Published As

Publication number Publication date
ATE71524T1 (de) 1992-02-15
IE852942L (en) 1986-05-23
AU4999785A (en) 1986-05-29
EP0183457B1 (de) 1992-01-15
FR2573652A1 (fr) 1986-05-30
AU4431189A (en) 1990-02-22
GB2167300A (en) 1986-05-29
PT81538A (en) 1985-12-01
GB8528190D0 (en) 1985-12-18
JPS61143318A (ja) 1986-07-01
EP0183457A3 (en) 1987-04-15
NZ214295A (en) 1988-07-28
GR852791B (de) 1986-03-21
CH666816A5 (fr) 1988-08-31
DK541285A (da) 1986-05-24
IL77086A0 (en) 1986-04-29
BE903701A (fr) 1986-05-22
DK541285D0 (da) 1985-11-22
FR2573652B1 (fr) 1988-09-02
GB2167300B (en) 1988-11-23
IE59195B1 (en) 1994-01-26
ZA858914B (en) 1987-07-29
EP0183457A2 (de) 1986-06-04
JPH0639379B2 (ja) 1994-05-25
DE3585211D1 (de) 1992-02-27
CA1267848A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
LU86172A1 (fr) Composition aqueuse de cromoglycate de sodium
EP0639069B1 (de) Okulaerdarreichungsform und verfahren zu ihrer herstellung
KR101433152B1 (ko) 안과용 약물의 전달에 유용한 젤
FR2588189A1 (fr) Composition pharmaceutique de type a transition de phase liquide-gel
JP2000508646A (ja) 眼における滞留時間の長い目薬組成物
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
FR2660193A1 (fr) Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.
EP0594770B1 (de) Oxicam und oxicamderivate enthaltende ophthalmische zusammensetzungen
RU2136252C1 (ru) Противовоспалительные глазные капли
OA12462A (fr) Composition pharmaceutique à base de macrolides pour application locale en ophtalmologie.
BE1005196A0 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
CH674937A5 (de)
FR2529457A1 (fr) Pommade ophtalmique comprenant une ou plusieurs paraffines et de la lanoline acetylee et procede pour la produire
CA2863180A1 (fr) Formulations liquides de sulfamides hypoglycemiants
BE1005615A3 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
EP3377061A1 (de) Mirabegron zur behandlung von netzhauterkrankungen
CN1087169C (zh) 抗炎症点眼剂
EP0433140B1 (de) Neues Arzneimittel mit antiallergischer Wirkung und verzögerter Wirkstofffreigabe
FR2537435A1 (fr) Nouvelle association medicamenteuse a base d'un alcaloide hydrogene de l'ergot de seigle et d'heparine
EP1336404A1 (de) Emulgierte ophthalmische Zusammensetzung
FR2906471A1 (fr) Nouvelles solutions injectables a base d'acide hyaluronique
FR2746014A1 (fr) Composition ophtalmologique du type subissant une transition de phase liquide-gel
BE547955A (de)